Prof. Sacks, USA discusses the available data on the PPAR gamma agonist - Pioglitazone. His analysis is based on the PROACTIVE and IRIS (Ischemic Stroke or Transient Ischemic Attack) studies.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In

five + eight =